Seed Fonds Aachen logo

Seed Fonds Aachen

Europe, Nordrhein-Westfalen, Germany, Aachen

Description

Seedfonds Aachen is a prominent venture capital fund dedicated to fostering innovative and technology-oriented start-ups primarily within the Aachen region and the broader Rhineland area of Germany. Established to support the vibrant entrepreneurial ecosystem, the fund is managed by a consortium of experienced partners, including BM-T Beteiligungsmanagement Thüringen GmbH and S-UBG AG, both well-regarded entities in the German venture capital landscape. Its strategic focus lies in identifying and nurturing early-stage companies with high growth potential, contributing significantly to regional economic development by transforming groundbreaking ideas into successful businesses.

The fund's investment strategy targets seed and early-stage companies across a diverse range of high-tech sectors. These include Information and Communication Technologies (ICT), life sciences, medical technology, advanced materials, and production technology. Seedfonds Aachen typically provides initial financing rounds of up to 1.5 million Euros (approximately $1.62 million USD), demonstrating its commitment to substantial early-stage support. Beyond the initial investment, the fund has the capacity for follow-on financing, potentially investing a total of up to 3 million Euros (approximately $3.24 million USD) per company throughout its lifecycle, enabling portfolio companies to scale and achieve their milestones.

Seedfonds Aachen plays a crucial role in the regional innovation ecosystem, acting as a vital bridge between cutting-edge research and market commercialization. Its operations are significantly bolstered by public funding, including support from the European Regional Development Fund (ERDF) and the State of North Rhine-Westphalia. This public-private partnership model underscores its mission to not only generate financial returns but also to stimulate job creation and technological advancement within the region. The fund's consistent focus on scalable, innovative ventures from the Rhineland underscores its commitment to strengthening Germany's position as a hub for deep tech and entrepreneurial excellence.

Investor Profile

Seed Fonds Aachen has backed more than 34 startups, with 0 new investments in the last 12 months alone. The firm has led 17 rounds, about 50% of its total and boasts 7 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown, Seed, Series A rounds (top funding stages).
  • Majority of deals are located in Germany.
  • Strong thematic focus on Biotechnology, Health Care, Software.
  • Typical check size: $270K – $1.6M.

Stage Focus

  • Series Unknown (35%)
  • Seed (35%)
  • Series A (15%)
  • Series B (12%)
  • Series C (3%)

Country Focus

  • Germany (91%)

Industry Focus

  • Biotechnology
  • Health Care
  • Software
  • Medical
  • Medical Device
  • Manufacturing
  • E-commerce
  • Life Science
  • Electronics
  • Enterprise Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Seed Fonds Aachen frequently co-invest with?

NRW.BANK
Europe, Nordrhein-Westfalen, Germany, Düsseldorf
Co-Investments: 4
KfW
Europe, Hessen, Germany, Frankfurt
Co-Investments: 7
TechVision Fund
Europe, Nordrhein-Westfalen, Germany, Aachen
Co-Investments: 5
Sagona Capital, Inc.
North America, Pennsylvania, United States, Philadelphia
Co-Investments: 1
Merus Capital
North America, California, United States, Menlo Park
Co-Investments: 2
DI
Europe, Nordrhein-Westfalen, Germany, Aachen
Co-Investments: 6
S-UBG Group
Europe, Nordrhein-Westfalen, Germany, Aachen
Co-Investments: 6
Berlin Venture Partners
Europe, Berlin, Germany, Berlin
Co-Investments: 1
MIG Capital
Europe, Bayern, Germany, München
Co-Investments: 2
SquareOne Venture Capital
Europe, Berlin, Germany, Berlin
Co-Investments: 2

What are some of recent deals done by Seed Fonds Aachen?

Silexica

Cologne, Nordrhein-Westfalen, Germany

Silexica provides programming tools that accelerate the journey from software to application-specific hardware systems

Application Specific Integrated Circuit (ASIC)Developer ToolsEmbedded SoftwareEmbedded SystemsEnterprise SoftwareField-Programmable Gate Array (FPGA)Software
Series BJun 21, 2018
Amount Raised: $18,000,000
Hemovent

Aachen, Nordrhein-Westfalen, Germany

​​​Hemovent is an emerging medical device company that has developed disruptive technology.

BiotechnologyHealth CareMedicalMedical Device
Series AJul 25, 2017
Amount Raised: $2,328,904
Innsystec

Aachen, Nordrhein-Westfalen, Germany

Hardware Software

SeedJun 7, 2017
Silexica

Cologne, Nordrhein-Westfalen, Germany

Silexica provides programming tools that accelerate the journey from software to application-specific hardware systems

Application Specific Integrated Circuit (ASIC)Developer ToolsEmbedded SoftwareEmbedded SystemsEnterprise SoftwareField-Programmable Gate Array (FPGA)Software
Series ANov 28, 2016
Amount Raised: $8,000,000
antibodies-online.com

Aachen, Nordrhein-Westfalen, Germany

antibodies-online is a vendor-independent marketplace for antibodies, ELISA kits, and related research reagents.

BiotechnologyE-CommerceLife ScienceMarketplace
Series UnknownOct 21, 2016
KLANG

Aachen, Nordrhein-Westfalen, Germany

They believe that a high quality and transparent monitor sound is the key to good live performances

Consumer ElectronicsElectronicsHardwareMusic
Series BJul 7, 2016
Picavi

Herzogenrath, Nordrhein-Westfalen, Germany

Picavi GmbH is the first company in the world to have developed order picking with smart glasses.

SoftwareWearables
Series CApr 26, 2016
Hemovent

Aachen, Nordrhein-Westfalen, Germany

​​​Hemovent is an emerging medical device company that has developed disruptive technology.

BiotechnologyHealth CareMedicalMedical Device
Series AFeb 10, 2016
Amount Raised: $6,000,000
aquila biolabs

Baesweiler, Nordrhein-Westfalen, Germany

aquila biolabs is a start-up focusing on the development of innovative laboratory devices for the analysis of shake-flask fermentations.

BiopharmaBiotechnologyLife Science
SeedNov 10, 2015
RLK Klimatechnik

Krefeld, Nordrhein-Westfalen, Germany

RLK Klimatechnik providing ventilation and air-conditioning engineering.

Building MaterialManufacturing
Series UnknownApr 10, 2015